Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Generic Pharmasec has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 13th February 2020 at 02:00 PM at its registered office to consider, approve and take on record the Un-Audited Financial Results along with Limited Review Report for the Quarter ended 31st December 2019 prepared in terms of IND-AS, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015; closure of trading window from 01st January 2020, and end 48 hours after the results are made public on 13th February 2020, as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 for Directors and Designated Employees as defined in the Code of Conduct for Prevention of Insider Trading of the Company; and any other matter with the permission of the Chair.
The above information is a part of company's filings submitted to BSE.
Company Name | CMP |
---|---|
Sudarshan Chemicals | 1130.35 |
Bodal Chemicals | 69.83 |
Shree Pushkar Chem | 351.95 |
Kiri Industries | 658.80 |
Bhageria Industries | 201.00 |
View more.. |